AxogenAXGN
NASDAQElectromedical Equipment
No cached AI snapshot yet for AXGN.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
622 employees51.90M shares outstandinglisted 1986-12-17
Next earnings ~May 5, 2026 · Ex-dividend Jan 27, 2010 · Dividend $1.00 irregular
About Axogen
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Latest News
Showing market-wide stock news
USD/JPY Price Forecast: Retreats from 155.50 with Fed’s policy in focus
Equities: Fed focus and energy shock – Deutsche Bank
Euro makes a run at 1.15, December hike groundwork is set to continue
Factbox-Major brokerages’ forecasts for S&P 500 index in 2026
Treasury ETF shorts shift toward belly ahead of Fed decision
BoE to 'stand ready to hike', committee remains 'deeply divided'
Related Stocksin Electromedical Equipment
Ready to see the live AI view on AXGN?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing AXGN side-by-side with live signals.